Farris Jackson
Fenton, MONPI 1083618904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by GSK at 31.5% of the total. Reporting peaked in 2019 at $983 and has fallen 89.0% since, to $108 in 2023.
Across 200 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$915
- AstraZeneca$650
- Boehringer Ingelheim$339
- Sanofi$136
- Regeneron Healthcare Solutions, Inc.$132
- Mylan Specialty L.p.$119
- plus $611 from 16 others
What the payments were for
- Food & beverage$2,899100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 81 | $915 |
| AstraZeneca | 39 | $650 |
| Boehringer Ingelheim | 24 | $339 |
| Sanofi | 8 | $136 |
| Regeneron Healthcare Solutions, Inc. | 7 | $132 |
| Mylan Specialty L.p. | 7 | $119 |
| Philips North America LLC | 7 | $97 |
| Genentech USA, Inc. | 5 | $89 |
| Boston Scientific | 3 | $76 |
| Vapotherm Inc | 3 | $56 |
| Johnson & Johnson | 2 | $37 |
| Insmed, Inc. | 2 | $35 |
| Novartis | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 2 | $32 |
| Natus Medical Incorporated | 1 | $28 |
| Edwards Lifesciences | 1 | $23 |
| Baxter Healthcare | 1 | $23 |
| Merck | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Grifols USA, LLC | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Covis Pharma GmbH | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.